Switch from conventional to every other day hemodialysis: A comparison pilot study

ASAIO Journal

Volumn 55, Issue 1, 2009, Pages 41-46

  Katopodis, Konstantinos P ^a   Dounousi, Evangelia ^a   Challa, Anna ^b   Pappas, Kostas ^a   Kalaitzidis, Rigas ^a   Siamopoulos, Kostas C ^a,c  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BODY WEIGHT; EJECTION FRACTION; HEMOGLOBIN LEVELS; LEFT VENTRICULAR; PILOT STUDIES;

BLOOD PRESSURE; HEMODIALYZERS; MERCURY (METAL); UREA;

DIALYSIS;

ANTIHYPERTENSIVE AGENT; CALCIUM; CREATININE; FERRITIN; HEMOGLOBIN; IRON; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE; RECOMBINANT ERYTHROPOIETIN; SERUM ALBUMIN; UREA; VITAMIN D;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLE; DRUG DOSE REDUCTION; DRUG UTILIZATION; ELECTROCARDIOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; GLOMERULONEPHRITIS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; IRON BLOOD LEVEL; IRON THERAPY; MAGNESIUM BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; PALLIATIVE THERAPY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REBOUND; RENOVASCULAR HYPERTENSION; TREATMENT OUTCOME; UREA BLOOD LEVEL; UREMIA; WEIGHT REDUCTION; BLOOD PRESSURE; BODY WEIGHT; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

BLOOD PRESSURE; BODY WEIGHT; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PILOT PROJECTS; RENAL DIALYSIS; STROKE VOLUME; UREMIA; VENTRICULAR FUNCTION, LEFT;

EID: 62449125946     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e318191f153     Document Type: Article

References (41)

1. Cambi V, Savazzi G, Arisi L, et al: Short dialysis schedules: Finally ready to become routine? Proc Eur Dial Transplant Assoc 11: 112-120, 1975.
2. Depner T: Benefits of more frequent dialysis: Lower TAC at the same KT/V. Nephrol Dial Transplant 13(Suppl 6): 20-24, 1998.
3. Kjellstrand CM, Evans RL, Peterson RJ, et al: The "unphysiology" of dialysis: A major cause of dialysis side effects? Kidney Int 7(Suppl 2): 30-34, 1975.
4. Mastrangelo F, Alfonso L, Napoli M, et al: Increased frequency of hemodialysis sessions reduces the mortality in hemodialysis. Perit Dial Int 18(Suppl 1): S78, 1998.
5. Williams AW, O'Sullivan DA, McCarthy JT: Slow nocturnal and short daily hemodialysis: A comparison. Semin Dial 12: 431- 439, 1999.
6. Birchem JA, Fraley MA, Senkottaiyan N, Alpert MA: Influence of hypertension on cardiovascular outcomes in hemodialysis patients. Semin Dial 18: 391-395, 2005.
7. O'Sullivan DA, McCarthy JT, Kumar J, Williams AW: Improved biochemical variables, nutrient intake, and hormonal factors in slow nocturnal hemodialysis: A pilot study. Mayo Clin Proc 73: 1035-1045, 1998.
8. Pierratos A, Ouwendyk M, Van Francoeur RS, et al: Nocturnal hemodialysis: Three year experience. J Am Soc Nephrol 9: 859-868, 1998.
9. Locatelli F, Buoncristiani U, Canaud B, et al: Dialysis dose and frequency. Nephrol Dial Transplant 20: 285-296, 2005.
10. K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy. Am J Kidney Dis 37(Suppl 1): S15-S55, 2001.
11. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 24: 2413-2446, 1997.
12. K/DOQI Clinical Practice Guidelines for Anemia. Am J Kidney Dis 37(Suupl 1): S186-S235, 2001.
13. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 39(Suupl 3): S1-S202, 2003.
14. Challa A, Bevington A, Anger CM, et al: A technique for the measurement of orthophosphate in human eryhtorocytes eryth-rocytes and some studies of its determinants. Clin Sci 69: 429-434, 1985.
15. Pedrini LA, Zereik S, Rasmy S: Causes, kinetics and clinical implications of post-hemodialysis urea rebound. Kidney Int 34: 817-824, 1998.
16. Daugirdas JT, Schneditz D: Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J 41: M719-M724, 1995.
17. Garred LJ, Barichello DL, Canaud BC, McCready WG: Simple equations for protein catabolic rate determination from pre dialysis and post dialysis blood urea nitrogen. ASAIO J 41: 889-895, 1995.
18. Lang M, Bierig M, Devereux RB, et al: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463, 2005.
19. Devereux R, Reichek N: Echocardiographic determination of left ventricular mass in man. Circulation 55: 1325-1350, 1997.
20. Hammond IW, Devereux RB, Alderman MH: The prevalence and correlation of echocardiographic left ventricular hypertrophy among employer patients with uncomplicated hypertension. J Am Coll Cardiol 7: 639-650, 1986.
21. Nersallah G, Suri R, Moist L, et al: Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 42(Suppl 1): S13-S17, 2003.
22. Pierratos A, Ouwendyk M: Nocturnal hemodialysis: Five years later. Semin Dial 12: 419-423, 1999.
23. Chan CT, Harvey PJ, Picton P, et al: Short-term blood pressure, noradrenergic and vascular effects of nocturnal home hemodialysis. Hypertension 42: 925-931, 2002.
24. Chan C, Floras J, Miller JA, et al: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61: 2235-2239, 2002.
25. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286-290, 1989.
26. Mastrangelo F, Alfonso L, Napoli M, et al: Dialysis with increased frequency of sessions (Lecce dialysis). Nephrol Dial Transplant 13(Suppl 6): 139-147, 1998.
27. Nakai S, Shenzato T, Takai F, et al: Relationship of protein catabolic rate of Kt/V with mortality. ASAIO J 39: M602-M605, 1993.
28. Kopple JD, Berge R, Houser H, et al: [Modification of diet in renal disease (MDRD) study group]. Nutritional status of patients with different levels of chronic renal insufficiency. Kidney Int 34(Suppl 27): S184-S194, 1989.
29. Traeger J, Sibai-Galland R, Delawari E, Arkouche W: Daily versus standard hemodialysis: One year experience. Artif Organs 22: 558-563, 1998.
30. Buoncristiani U, Cairo G, Giambini L, et al: Dramatic improvement in clinical-metabolic parameters and quality of life with daily dialysis. Int J Artif Organs 12(Suppl 4): 133-136, 1989.
31. Buoncristiani U, Quentaliani G, Cozzari M, Regarolo M: Daily dialysis: Long-term clinical metabolic results. Kidney Int 33(Suppl 24): S137-S140, 1988.
32. Braun J, Oldendorf M, Moshage W, et al: Electron beam computer tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidner Dis 27: 394-401, 1996.
33. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients. Am J Kidney Dis 31: 607-617, 1998.
34. Nessim SJ, Jassal SV, Fung SV, Chan CT: Conversion from conventional to nocturnal hemodialysis improves vitamin D levels. Kidney Int 71: 1172-1176, 2007.
35. Bevington A, Brough D, Baker EF, et al: Metabolic acidosis is a potent stimulus for cellular inorganic phosphate generation in uraemia. Clinical Science 88: 405-412, 1995.
36. Knochel JP, Agarwal R: Hypophoshatemia and hyperphosphatemia, in Brenner BM. The Kidney. Philadelphia: WB Saundres, 1996, pp. 1086-1133.
37. Buoncristiani U: Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 13(Suppl 60): S148-S151, 1998.
38. Rao M, Muirhead N, Klarenbach S, et al: Management of anemia with quotidian hemodialysis. Am J Kidney Dis 42(Suppl 1): S18-S23, 2003.
39. Macdougall IC: Role of uremic toxins in exacerbating anemia in renal failure. Kidney Int 78(Suppl): S67-S72, 2001.
40. Kooistra MP, Vos PF: Daily home hemodialysis: Towards a more physiological treatment of patients with ESRD. Semin Dial 12: 424-430, 1999.
41. Krocker A, Clarc WF, Heidenheim AP: An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis 42 (Suppl 1): S49-S55, 2003.